Hermetica Superfood Encyclopedia
The Short Answer
Microsorum grossum rhizomes contain phenolic acids, flavonoids, and terpenoids—bioactive classes documented in the closely related species Microsorum scolopendria—that act through COX-2 inhibition, radical scavenging, and disruption of bacterial biofilm gene expression (rsbU, spa). Samoan traditional medicine employs the rhizome specifically for respiratory complaints including coughs and asthma, though no controlled clinical trials have quantified its efficacy in human populations.
CategoryRoot
GroupPacific Islands
Evidence LevelPreliminary
Primary Keywordtalia fern benefits
Talia — botanical close-up
Health Benefits
**Respiratory Symptom Relief (Traditional)**
The rhizome is used in Samoan ethnomedicine to address coughs and asthma; anti-inflammatory phenolics present in related Microsorum species may reduce airway inflammation via selective COX-2 inhibition, though this has not been tested in human respiratory models.
**Antioxidant Activity**: Closely related M
scolopendria rhizome acetone extracts (RAE) reduce reactive oxygen species by up to 87.35% against Staphylococcus epidermidis in human dermal fibroblast cells, suggesting meaningful radical-scavenging capacity attributable to pyrogallol (9.32%), isoxanthohumol (9.09%), and cirsimaritin (8.45%).
**Anti-Inflammatory Potential**
Extracts from taxonomically related Microsorum species selectively inhibit cyclooxygenase-2 (COX-2) over COX-1, a pharmacologically favorable profile that minimizes gastric risk while suppressing prostaglandin-mediated inflammation, though M. grossum itself has not been directly assayed.
**Antimicrobial and Antibiofilm Action**
Polyphenolic constituents including isoxanthohumol and kaempferol-class compounds inhibit bacterial biofilm formation at concentrations of 128 µg/mL in vitro by downregulating biofilm-regulatory genes, potentially supporting immune defense against skin and systemic pathogens.
**Phenolic Acid Richness**
Phenolic acids constitute 46–57% of relative abundance in rhizome and leaf extracts of related species, with hydroxycinnamic acid conjugates such as p-coumaroyl tartaric acid (28% in leaf hydroalcoholic extract) and feruloyl tartaric acid (12.8%) contributing broad-spectrum antioxidant and cytoprotective effects.
**Potential Skin Protective Effects**
In vitro testing in human dermal fibroblast (HDFa) cells exposed to Staphylococcus aureus and S. epidermidis showed a 64–87% reduction in intracellular ROS following treatment with related Microsorum RAE, suggesting dermal cytoprotective potential if extrapolated cautiously to M. grossum.
**Flavonoid-Mediated Cellular Protection**: Kaempferol 3-O-glucuronide (1
41% in leaf hydroalcoholic extract of related species) and cirsimaritin are recognized inhibitors of pro-inflammatory kinase pathways; their presence in Microsorum species supports a mechanistic basis for traditional anti-inflammatory applications, pending direct study of M. grossum.
Origin & History
Natural habitat
Microsorum grossum, commonly called talia in Samoa or lauaʻe (maile-scented fern) in Hawaiʻi, is a terrestrial and epiphytic fern native to a broad Pacific range spanning Australia, Polynesia, and extending east to Pitcairn Island. It thrives in low-elevation tropical and subtropical forests, frequently colonizing tree trunks, rocky substrates, and moist forest floors at elevations below 500 m. The species has not been formally cultivated as an agricultural or horticultural crop but spreads naturally via spores and creeping rhizomes in humid Pacific Island environments.
“In Samoan traditional medicine, the plant locally called talia (Microsorum grossum) has been documented as a remedy for respiratory conditions, specifically coughs and asthma, with the rhizome serving as the primary medicinal part—a use pattern consistent with Pacific Island ethnobotanical traditions that frequently emphasize fern rhizomes for their concentrated secondary metabolites. The closely related lauaʻe (broadly applied to Microsorum species in Hawaiʻi) holds deep cultural significance in Hawaiian tradition as a fragrant fern associated with the forest deity and used to scent kapa cloth, lei, and ceremonial spaces, though this cultural role is aesthetic and spiritual rather than strictly medicinal. On Rapa Nui (Easter Island), M. scolopendria (Matu'a Pua'a) forms part of the indigenous pharmacopoeia for general illness treatment, reflecting the wider Polynesian tradition of utilizing Microsorum ferns as versatile healing plants. Taxonomic ambiguity among Pacific Microsorum species—particularly the longstanding confusion between M. grossum, M. scolopendria, and related taxa—has historically complicated the attribution of specific therapeutic uses to individual species in ethnobotanical literature.”Traditional Medicine
Scientific Research
No peer-reviewed studies have been conducted specifically on Microsorum grossum (talia) as a medicinal or nutritional ingredient, and no clinical trials of any design exist for either M. grossum or its close relative M. scolopendria. Available evidence consists entirely of in vitro investigations of M. scolopendria extracts, including cell-free antioxidant assays (DPPH, ORAC) and infection models using human dermal fibroblast (HDFa) cells exposed to Staphylococcus aureus and S. epidermidis, as well as RP-HPLC-MS phytochemical profiling studies from Rapa Nui ethnobotanical research programs. These preclinical studies, while generating quantifiable data (e.g., 87.35% ROS reduction, 128 µg/mL biofilm inhibitory concentration), cannot be translated directly to human therapeutic claims due to the absence of pharmacokinetic data, animal toxicology, and dose-escalation studies. The evidence base for M. grossum specifically remains at the level of ethnobotanical observation only, with phytochemical data inferred by taxonomic proximity rather than direct analysis.
Preparation & Dosage
Traditional preparation
**Traditional Samoan Preparation**
Rhizome collected, typically dried or used fresh, and prepared as a decoction (boiled water extract) for oral administration to address coughs and asthma; exact volumes and frequencies are not standardized in published ethnobotanical records.
**Research Extract Forms (Related Species)**
Rhizome acetone extract (RAE) and leaf hydroalcoholic extract (HAE) have been employed in in vitro studies at concentrations up to 128 µg/mL; these laboratory-grade preparations are not commercially available as consumer supplements.
**No Established Supplemental Dose**
No therapeutic dose range, standardized extract specification, or bioavailability-adjusted dosing protocol has been established for M. grossum or M. scolopendria in any human study.
**Standardization**
No commercial standardization to any specific marker compound (e.g., pyrogallol, isoxanthohumol, or p-coumaroyl tartaric acid) exists for products derived from either Microsorum species.
**Timing and Administration**
No clinical guidance on timing, frequency, or route of administration beyond traditional oral decoction use is available in the current literature.
Nutritional Profile
Microsorum grossum has not been subjected to proximate nutritional analysis; no data on macronutrient (carbohydrate, protein, lipid), caloric, fiber, mineral, or vitamin content are available in the published literature for either the rhizome or leaf. Phytochemical profiling of the closely related M. scolopendria reveals a phenolic-dominant secondary metabolite profile, with phenolic acids comprising 46–57% relative abundance in rhizome and leaf extracts, flavonoids as the secondary class, and terpenoids enriched particularly in leaf hexane fractions. Key identified compounds in related-species extracts include pyrogallol (9.32%), isoxanthohumol (9.09%), cirsimaritin (8.45%), p-coumaroyl tartaric acid (28%), feruloyl tartaric acid (12.8%), protocatechuic acid 4-O-glucoside (~2%), and kaempferol 3-O-glucuronide (1.41%), all expressed as relative percentage abundance in specific extract fractions rather than as absolute concentrations per gram of dried plant material. Bioavailability data for these compounds specifically from Microsorum preparations are entirely absent from the literature.
How It Works
Mechanism of Action
Polyphenolic compounds identified in the closely related Microsorum scolopendria—including isoxanthohumol, cirsimaritin, and kaempferol 3-O-glucuronide—selectively inhibit cyclooxygenase-2 (COX-2) enzyme activity over COX-1, thereby reducing synthesis of pro-inflammatory prostaglandins without the full gastric liability associated with non-selective COX inhibition. Radical-scavenging constituents such as pyrogallol and hydroxycinnamic acid conjugates (p-coumaroyl tartaric acid, feruloyl tartaric acid) neutralize reactive oxygen species through hydrogen atom transfer and single-electron transfer mechanisms, as quantified by DPPH and ORAC in vitro assays. At the microbial level, polyphenols in rhizome extracts downregulate the staphylococcal regulatory genes rsbU and spa, which govern sigma-B stress response and protein A surface adhesin expression respectively, thereby destabilizing biofilm architecture and enhancing susceptibility to antibiotics at 128 µg/mL. No molecular pharmacology data exist specifically for M. grossum; all mechanistic inference is extrapolated from in vitro studies on M. scolopendria.
Clinical Evidence
No clinical trials have been conducted for Microsorum grossum (talia) or its taxonomically related species M. scolopendria in any human population. The Samoan traditional use of the rhizome for coughs and asthma has not been evaluated in observational cohort studies, randomized controlled trials, or even case series in the published biomedical literature. All quantitative outcomes derive from in vitro cell culture and biochemical assay systems, which preclude calculation of human-relevant effect sizes, number-needed-to-treat values, or confidence intervals. Clinical confidence in the efficacy and safety of M. grossum for any indication is therefore very low, and formal evidence-based recommendations cannot be issued pending foundational pharmacological and toxicological research.
Safety & Interactions
No formal toxicology studies, adverse event reports, or drug interaction data exist for Microsorum grossum, and the limited in vitro data from related M. scolopendria research show no overt cytotoxicity in human dermal fibroblast (HDFa) cells at concentrations up to 128 µg/mL—a finding that cannot be extrapolated to human oral safety without pharmacokinetic and in vivo toxicology investigation. The presence of pyrogallol, a phenolic compound with known nephrotoxic and hemolytic potential at high doses in animal models, warrants caution, as its concentration and oral bioavailability from rhizome preparations have not been characterized. No drug interactions have been identified or studied; however, given the COX-2 inhibitory activity suggested in related-species research, theoretical interactions with NSAIDs, anticoagulants, and corticosteroids should be considered in clinical contexts. Guidance for pregnant or lactating individuals, pediatric populations, or those with hepatic or renal impairment cannot be provided due to a complete absence of relevant safety data, and use of this plant beyond traditional culinary or low-dose traditional medicine contexts is not supported by current evidence.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Microsorum grossumlauaʻemaile-scented fernMatu'a Pua'a (related species)Microsorum scolopendria (taxonomic synonym/confused species)
Frequently Asked Questions
What is talia used for in Samoan traditional medicine?
In Samoan ethnomedicine, the rhizome of talia (Microsorum grossum) is traditionally used to treat respiratory complaints, specifically coughs and asthma. The preparation typically involves the rhizome as the active plant part, consistent with Pacific Island fern medicine traditions, though exact preparation methods and doses have not been formally standardized or validated in clinical research.
Has Microsorum grossum been scientifically studied for its health effects?
Microsorum grossum itself has not been the direct subject of any published pharmacological or clinical study; available scientific data derive from research on the closely related species Microsorum scolopendria, which has demonstrated antioxidant, anti-inflammatory, and antimicrobial properties exclusively in in vitro (laboratory cell culture) experiments. No human trials, animal toxicology studies, or pharmacokinetic investigations have been conducted for either species, making the evidence base very preliminary.
What bioactive compounds are found in Microsorum ferns?
Research on the related species Microsorum scolopendria identifies phenolic acids (46–57% relative abundance) as the dominant compound class, with notable constituents including p-coumaroyl tartaric acid (28% in leaf hydroalcoholic extract), pyrogallol (9.32%), isoxanthohumol (9.09%), cirsimaritin (8.45%), feruloyl tartaric acid (12.8%), and kaempferol 3-O-glucuronide (1.41%). These compounds have not been directly measured in Microsorum grossum, but the close taxonomic relationship suggests a similar phytochemical profile.
Is talia fern safe to consume as a supplement?
There is no established safety profile for Microsorum grossum; no toxicology studies, clinical adverse event data, or drug interaction studies have been published for this species or its close relative M. scolopendria. The presence of pyrogallol—a phenolic compound with nephrotoxic and hemolytic potential in high animal-model doses—warrants caution, and no safe supplemental dose range has been identified. Traditional use appears to be low-dose and episodic, but this does not constitute a formal safety endorsement.
What is the difference between Microsorum grossum and Microsorum scolopendria?
Microsorum grossum (talia, lauaʻe) and Microsorum scolopendria (Matu'a Pua'a on Rapa Nui) are two related but distinct fern species within the same genus that have historically been confused due to overlapping morphology and shared Pacific Island distribution. Microsorum scolopendria has been the subject of phytochemical and in vitro pharmacological studies linked to Rapa Nui traditional medicine, while M. grossum is documented in Samoan ethnomedicine but lacks direct scientific study; taxonomic clarity between these species is essential for accurate attribution of medicinal properties and safety data.
Does talia (Microsorum grossum) interact with asthma or respiratory medications?
While talia rhizome is traditionally used for respiratory symptoms, there is insufficient clinical evidence to determine whether it interacts with common asthma medications such as bronchodilators or corticosteroids. The phenolic compounds in Microsorum species may theoretically have mild anti-inflammatory effects, but concurrent use with prescription respiratory medications should only occur under healthcare provider supervision. No drug interaction studies have been conducted specifically with Microsorum grossum.
Is talia safe to use during pregnancy or while breastfeeding?
There are no clinical safety studies evaluating Microsorum grossum use during pregnancy or lactation, so it is not recommended during these periods without medical guidance. Traditional Samoan ethnomedicinal use does not constitute safety evidence for pregnant or nursing individuals. Women in these groups should consult a healthcare provider before considering talia supplementation.
What is the most effective form of talia—fresh rhizome, dried powder, or extract?
Most traditional Samoan preparations use the dried or fresh rhizome, but no comparative bioavailability studies have been conducted to determine which form is most effective for respiratory or antioxidant benefits. Acetone and water extracts of related Microsorum species show in vitro antioxidant activity, though their superiority over whole rhizome preparations has not been tested in humans. The optimal form and extraction method for Microsorum grossum remain undefined by clinical research.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w talia-microsorum-grossum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
